Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

[P16NIK4a expression in premalignant cervical lesions].

Bolanca IK, Simon SK, Sentija K, Duić Z, Kukura V, Zovko G, Valetić J, Vranes J.

Acta Med Croatica. 2011 Sep;65 Suppl 1:53-8. Croatian.

PMID:
23126030
2.

Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.

Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S.

Coll Antropol. 2010 Mar;34(1):19-24.

PMID:
20432728
3.

Immunocytochemical expression of p16INK4A and Ki-67 in cytologically negative and equivocal pap smears positive for oncogenic human papillomavirus.

Longatto Filho A, Utagawa ML, Shirata NK, Pereira SM, Namiyama GM, Kanamura CT, Santos Gda C, de Oliveira MA, Wakamatsu A, Nonogaki S, Roteli-Martins C, di Loreto C, Mattosinho de Castro Ferraz Mda G, Maeda MY, Alves VA, Syrjänen K.

Int J Gynecol Pathol. 2005 Apr;24(2):118-24.

PMID:
15782067
4.
5.

p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.

Dray M, Russell P, Dalrymple C, Wallman N, Angus G, Leong A, Carter J, Cheerala B.

Pathology. 2005 Apr;37(2):112-24.

PMID:
16028838
7.

p16INK4A expression in cervical premalignant and malignant lesions.

Lambert AP, Anschau F, Schmitt VM.

Exp Mol Pathol. 2006 Apr;80(2):192-6. Epub 2005 Oct 28.

PMID:
16257403
8.

Clinical role of p16INK4a expression in liquid-based cervical cytology: correlation with HPV testing and histologic diagnosis.

Benevolo M, Vocaturo A, Mottolese M, Mariani L, Vocaturo G, Marandino F, Sperduti I, Rollo F, Antoniani B, Donnorso RP.

Am J Clin Pathol. 2008 Apr;129(4):606-12. doi: 10.1309/BEPQXTCQD61RGFMJ.

9.

Staining characteristics of p16INK4a: is there a correlation with lesion grade or high-risk human papilloma virus positivity?

Ozgul N, Cil AP, Bozdayi G, Usubutun A, Bulbul D, Rota S, Kose MF, Biri A, Haberal A.

J Obstet Gynaecol Res. 2008 Oct;34(5):865-71.

PMID:
18958930
10.
11.

The utility of p16(Ink4a) in discriminating between cervical intraepithelial neoplasia 1 and nonneoplastic equivocal lesions of the cervix.

Redman R, Rufforny I, Liu C, Wilkinson EJ, Massoll NA.

Arch Pathol Lab Med. 2008 May;132(5):795-9. doi: 10.1043/1543-2165(2008)132[795:TUOPID]2.0.CO;2.

PMID:
18466028
12.

p16(INK4a) is a useful marker of human papillomavirus integration allowing risk stratification for cervical malignancies.

Cheah PL, Looi LM, Teoh KH, Mun KS, Nazarina AR.

Asian Pac J Cancer Prev. 2012;13(2):469-72.

13.

Estimating clinical outcome of HPV induced cervical lesions by combination of capsid protein L1 and p16INK4a protein detection.

Bolanca IK, Sentija K, Simon SK, Kukura V, Vranes J.

Coll Antropol. 2010 Mar;34(1):31-6.

PMID:
20432730
14.

Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia.

Riethdorf L, Riethdorf S, Lee KR, Cviko A, Löning T, Crum CP.

Hum Pathol. 2002 Sep;33(9):899-904.

PMID:
12378514
15.
16.

Prognostic markers of high-grade squamous intraepithelial lesions: the role of p16INK4a and high-risk human papillomavirus.

Eleutério J Jr, Giraldo PC, Gonçalves AK, Cavalcante DI, de Almeida Ferreira FV, Mesquita SM, Morais SS.

Acta Obstet Gynecol Scand. 2007;86(1):94-8.

PMID:
17230296
17.

p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia.

Kong CS, Balzer BL, Troxell ML, Patterson BK, Longacre TA.

Am J Surg Pathol. 2007 Jan;31(1):33-43.

PMID:
17197917
18.

[Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions].

Jović M, Nenadić D, Magić Z, Zoltarevski L, Durdević-Vukomanović B, Tatomirović Z, Strelić N, Vojvodić D.

Vojnosanit Pregl. 2008 Mar;65(3):211-9. Serbian.

PMID:
18494269
19.

P16INK4a immunocytochemistry/immunohistochemistry: need for scoring uniformization to be clinically useful in gynecological pathology.

van Bogaert LJ.

Ann Diagn Pathol. 2012 Oct;16(5):422-6. doi: 10.1016/j.anndiagpath.2012.03.006. Epub 2012 Apr 24. Review.

PMID:
22537665
20.

Usefulness of CINtec® PLUS p16/Ki-67 double-staining in cytological screening of cervical cancer.

Yoshida T, Sano T, Kanuma T, Inoue H, Itoh T, Yazaki C, Obara M, Fukuda T.

Acta Cytol. 2011;55(5):413-20. doi: 10.1159/000331047. Epub 2011 Oct 8.

PMID:
21986167
Items per page

Supplemental Content

Write to the Help Desk